Skip to Main Content

09.10.03 - Maryland Racing Commission - Final Regulations

FINAL ACTION ON REGULATIONS
MARYLAND REGISTER, VOLUME 43, ISSUE 21,
FRIDAY, OCTOBER 14, 2016

Subtitle 10 RACING COMMISSION

09.10.03 Prohibited Acts

Authority: Business Regulation Article,§11-210; Annotated Code of Maryland

Notice of Final Action
[16-131-F]

On September 20, 2016, the Maryland Racing Commission adopted amendments to Regulation .01-1 under COMAR 09.10.03 Prohibited Acts. This action, which was proposed for adoption in 43:12 Md. R. 681 (June 10, 2016), has been adopted as proposed.

Effective Date: October 24, 2016.

J. MICHAEL HOPKINS
Executive Director

.01-1 Restricted Use of Medications and Other Substances.
The use of the following medications and other substances are permitted if quantitated at not more than the specified thresholds:
  A. — D. (text unchanged)
  D-1. Cetirizine quantitated at not more than 6 nanograms per milliliter of blood plasma or serum;
  D-2. Cimetidine quantitated at not more than 400 nanograms per milliliter of blood plasma or serum;

  E. — N. (text unchanged)
  N-1. Guaifenesin quantitated at not more than 12 nanograms per milliliter of blood plasma or serum;
  [N-1] N-2. (text unchanged)
  O. — S. (text unchanged)
  T. Omeprazole quantitated at not more than [1 nanogram] 10 nanograms per milliliter of [urine] blood plasma or serum;
  U. — W. (text unchanged)
  W-1. Ranitidine quantitated at not more than 40 nanograms per milliliter of blood plasma or serum;
  X. (text unchanged)
  Y. Xylazine quantitated at not more than [.01 nanograms] 200 picigrams per milliliter of blood plasma or serum;
  Z. — CC. (text unchanged)